CML also accumulated in the tumor xenografts and has been described as a candidate ligand of the receptor for advanced glycation end products (RAGE) receptor that has candidate oncogenic and proinflammatory functions in cancer (32). This evidence concerns the gene AGER and chronic myelogenous leukemia, BCR-ABL1 positive.